Approval to add to growing SUPRAX® Franchise MUMBAI, India and BALTIMORE, February 22, 2013 -- (Healthcare Sales & Marketing Network) --Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) ...
Biopharmaceuticals, Generics, FDA
Lupin , SUPRAX, Cefixime

Veteran Sales and Diagnostic Executive to Succeed R. Judd Jessup, Who Will Retire in March IRVINE, Calif., Feb. 22, 2013 -- (Healthcare Sales & Marketing Network) -- CombiMatrix Corporation (CBMX), a molecular diagnostics company performing DNA-based te...
Diagnostics, Personnel
CombiMatrix

FORT LAUDERDALE, Fla., Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- MAKO Surgical Corp. (MAKO), a medical device company that markets its RIO(R) Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty(R) joint specific applications, ...
Devices, Orthopaedic, Personnel
MAKO Surgical, Robotic Arm Interactive Orthopedic, MAKOplasty

AMSTERDAM--(Healthcare Sales & Marketing Network)--Tornier, N.V. (TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H. Mowry ...
Devices, Orthopaedic, Personnel
Tornier

MOUNTAIN VIEW, Calif. and BARCELONA, Spain, Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional, S.A., today announced that the European Commission has granted marketing authorizati...
Biopharmaceuticals, Regulatory
Alexza Pharmaceuticals, ADASUVE, Staccato loxapine, schizophrenia

WOODCLIFF LAKE, NJ. and MONTREAL, Quebec, Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., and Valeant Pharmaceuticals International, Inc. (VRX)(VRX) announced today that Valeant...
Biopharmaceuticals, Acquisitions
Valeant Pharmaceuticals, Eisai, Targretin, bexarotene

Latest Pipeline Advancement Expands Therapeutic Flexibility of System One LAWRENCE, Mass., Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- NxStage® Medical, Inc. (NXTM), a leading manufacturer of innovative dialysis products, today annou...
Devices, Regulatory
NxStage Medical, NxStage System One, dialysis

NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) today announced top-line results for a Phase 3 study that showed Lyrica® (pregabalin) Capsules CV were as effective as levetiracetam as an adjunctive therapy in adult epilepsy patients...
Biopharmaceuticals, Neurology
Pfizer, Lyrica, pregabalin, levetiracetam, epilepsy

NASHVILLE, Tenn., Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (CPIX) today announced that it has entered into an exclusive agreement with Sandor Medicaids Pvt. Ltd., an India-based pharmaceutical company, for...
Biopharmaceuticals, Licensing, Distribution
Cumberland Pharmaceuticals, Sandor Medicaids, Caldolor, ibuprofen

VILLA GUARDIA, Italy, Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- Gentium S.p.A. (GENT) (the "Company") announced today that, the Company had presented an oral explanation at the European Medicines Agency's ("EMA") Commit...
Biopharmaceuticals, Regulatory
Gentium, Defibrotide, hepatic veno-occlusive disease, stem cell transplantation

20-Year-Old Tiernee Gonzalez Begins Producing Urine Day Before Scheduled Surgery to Implant Permanent Catheter TUCSON, Ariz., Feb. 21, 2013 -- (Healthcare Sales & Marketing Network) -- At only 20 years old, Tiernee Gonzalez has been battling two major ...
Devices, Cardiology
SynCardia Systems, temporary Total Artificial Heart, heart failure

Ready for Anticipated Regulatory Approval and Launch of Iclusig® in Europe this Year CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(Healthcare Sales & Marketing Network)--ARIAD Pharmaceuticals, Inc. (ARIA) today announced the appointment of Jonathan E....
Biopharmaceuticals, Oncology, Personnel
ARIAD Pharmaceuticals, Iclusig, ponatinib

NATRELLE® Line Now Includes Saline, Round Silicone Gel and Newly Approved 410 Shaped Silicone Gel Options IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Allergan, Inc. (AGN) today announced that the company has received approval from the U...
Devices, FDA
Allergan, Natrelle, Silicone-Filled Breast Implant, breast implant

Leading Healthcare Facility Standardizes to Masimo Noninvasive Hemoglobin (SpHb®) and Acoustic Respiration Rate (RRa™) Technologies in Key Care Areas CHARLOTTESVILLE, Va. and IRVINE, Calif., Feb. 20, 2013 -- (Healthcare Sales & Marketing Network) -...
Devices, Monitoring
Masimo, Masimo SpHb, Masimo RRa, Masimo Radical-7, Pulse CO-Oximeters

Financing Validates the Attractiveness of VizAblate® REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Gynesonics, Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced tod...
Devices, Venture Capital
Gynesonics, uterine fibroids, VizAblate System

RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2013 -- (Healthcare Sales & Marketing Network) -- Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment of Ernest Mario, Ph...
Biopharmaceuticals, Personnel
Chimerix

Laboratory Contamination Determined as Likely Source of False Positive ST. LOUIS, MO--(Healthcare Sales & Marketing Network) - Mobius Therapeutics, the makers of Mitosol® (mitomycin for solution) Kit for Ophthalmic Use, announced today that the sour...
Biopharmaceuticals, Ophthalmology, Product Recall
Mobius Therapeutics, Mitosol Kit, mitomycin

ST. PAUL, MN--(Healthcare Sales & Marketing Network) - EnteroMedics Inc. ( NASDAQ : ETRM ), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Seni...
Devices, Personnel
EnteroMedics, neuroblocking, obesity, VBLOC , vagal blocking therapy

FORT LAUDERDALE, Fla., Feb. 20, 2013 -- (Healthcare Sales & Marketing Network) -- OrbusNeich today announced that OrbusNeich Medical GmbH and Orbus International B.V., subsidiaries of OrbusNeich Medical, Inc., (collectively, "OrbusNeich") have c...
Devices, Interventional Cardiology, Litigation
OrbusNeich, Boston Scientific, PROMUS Element, OMEGA PtCr, TAXUS Element

Breakthrough Peer Review Clinical Study Finds INSORB Staples Superior To Absorbable Suture For Closure of Contaminated Wounds MINNEAPOLIS, Feb. 20, 2013 -- (Healthcare Sales & Marketing Network) -- Incisive Surgical, Inc. today announced the sale of it...
Devices, Surgery
Incisive Surgical, INSORB , Absorbable Skin Stapler, skin closure